ImmunoPrecise Antibodies Debt to Equity Ratio 2022-2025 | IPA
Current and historical debt to equity ratio values for ImmunoPrecise Antibodies (IPA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ImmunoPrecise Antibodies debt/equity for the three months ending January 31, 2025 was 0.45.
| ImmunoPrecise Antibodies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-01-31 | $0.01B | $0.02B | 0.81 |
| 2024-10-31 | $0.02B | $0.02B | 0.84 |
| 2024-07-31 | $0.02B | $0.02B | 0.81 |
| 2024-04-30 | $0.02B | $0.03B | 0.77 |
| 2024-01-31 | $0.02B | $0.04B | 0.58 |
| 2023-10-31 | $0.02B | $0.04B | 0.45 |
| 2023-07-31 | $0.02B | $0.04B | 0.42 |
| 2023-04-30 | $0.02B | $0.04B | 0.35 |
| 2023-01-31 | $0.02B | $0.05B | 0.35 |
| 2022-10-31 | $0.02B | $0.05B | 0.34 |
| 2022-07-31 | $0.01B | $0.05B | 0.21 |
| 2022-04-30 | $0.02B | $0.06B | 0.24 |
| 2022-01-31 | $0.01B | $0.04B | 0.18 |
| 2021-10-31 | $0.01B | $0.04B | 0.19 |
| 2021-07-31 | $0.01B | $0.05B | 0.16 |
| 2021-04-30 | $0.01B | $0.04B | 0.18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.021B | $0.018B |
| ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.971B | 53.83 |
| Hims & Hers Health (HIMS) | United States | $11.505B | 119.54 |
| Tempus AI (TEM) | United States | $11.232B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.506B | 70.41 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Privia Health (PRVA) | United States | $3.041B | 208.92 |
| Clover Health Investments (CLOV) | United States | $1.916B | 0.00 |
| Enovis (ENOV) | United States | $1.889B | 10.53 |
| Schrodinger (SDGR) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.492B | 0.00 |
| Azenta (AZTA) | United States | $1.266B | 58.96 |
| Omnicell (OMCL) | United States | $1.189B | 20.98 |
| 10x Genomics (TXG) | United States | $1.055B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.565B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.424B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 833.33 |
| Claritev (CTEV) | United States | $0.350B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.293B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.211B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.086B | 0.00 |
| CareCloud (CCLD) | United States | $0.078B | 2.97 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |